|本期目录/Table of Contents|

[1]刘雅博 综述. SRCs与生殖系统疾病的关系[J].天津医科大学学报,2014,20(04):335-封三.
点击复制

 SRCs与生殖系统疾病的关系(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
20卷
期数:
2014年04期
页码:
335-封三
栏目:
综述
出版日期:
2014-07-08

文章信息/Info

Title:
-
文章编号:
1006-8147(2014)04-0335-03
作者:
刘雅博 综述
(天津市中心妇产科医院,天津 300199)
Author(s):
-
关键词:
核受体 甾体受体共调节因子生殖系统疾病 肿瘤
Keywords:
-
分类号:
R71
DOI:
-
文献标志码:
A
摘要:
-
Abstract:
-

参考文献/References:

[1]Xu J, Wu R C, O’malley B W. Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family[J]. Nat Rev Cancer, 2009,9(9):615
[2]王雪莹,王瑞安. 雌激素受体在肿瘤中的生物学作用[J]. 现代肿瘤医学, 2012,20(3):625
[3]Nguyen H D, Phan T T, Carraz M, et al. Estrogen receptor α/β-cofactor motif interactions; interplay of tyrosine 537/488 phosphorylation and LXXLL motifs[J]. Mol Biosyst, 2012,8(12):3134
[4]Bolt M J, Stossi F, Newberg J Y, et al. Coactivators enable glucocorticoid receptor recruitment to fine-tune estrogen receptor transcriptional responses[J]. Nucleic Acids Res, 2013,41(7):4036
[5]York B, O’malley B W. Steroid receptor coactivator (SRC) family: masters of systems biology[J]. J Biol Chem, 2010,285(50):38743
[6]Lanz R B, Bulynko Y, Malovannaya A, et al. Global characterization of transcriptional impact of the SRC-3 coregulator[J]. Mol Endocrinol, 2010,24(4):859
[7]Fenne I S, Helland T, Flågeng M H, et al. Downregulation of steroid receptor coactivator-2 modulates estrogen-responsive genes and stimulates proliferation of mcf-7 breast cancer cells[J]. PLoS One, 2013,8(7):e70096
[8]Johnson A B, O’malley B W. Steroid receptor coactivators 1, 2, and 3: critical regulators of nuclear receptor activity and steroid receptor modulator (SRM)-based Cancer therapy[J]. Mol Cell Endocrinol, 2012,348(2):430
[9]Moi L L, Flågeng M H, Gjerde J, et al. Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast Cancer[J]. BMC Cancer, 2012,12:247
[10]Palmieri C, Gojis O, Rudraraju B, et al. Expression of steroid receptor coactivator 3 in ovarian epithelial Cancer is a poor prognostic factor and a marker for Platinum resistance[J]. Br J Cancer, 2013,108(10):2039
[11]Thigpen T, dubois A, Mcalpine J, et al. First-line therapy in ovarian Cancer trials[J]. Int J Gynecol Cancer, 2011,21(4):756
[12]Geng C, He B, Xu L, et al. Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover[J]. Proc Natl Acad Sci U S A, 2013,110(17):6997
[13]Ou C W, Sun M, Sadej W, et al. Expression of nuclear receptor coactivators in the human fetal membranes at term before and after labor[J]. Obstet Gynecol Int, 2012,2012:717294
[14]Suzuki A, Horiuchi A, Oka K, et al. Immunohistochemical detection of steroid receptor cofactors in ovarian endometriosis: involvement of down-regulated SRC-1 expression in the limited growth activity of the endometriotic epithelium[J]. Virchows Arch, 2010,456(4):433
[15]Kumagami A, Ito A, Yoshida-Komiya H, et al. Expression patterns of the steroid receptor coactivator family in human ovarian endometriosis[J]. J Obstet Gynaecol Res, 2011,37(10):1269
[16]Han S J, Hawkins S M, Begum K, et al. A new isoform of steroid receptor coactivator-1 is crucial for pathogenic progression of endometriosis[J]. Nat Med, 2012,18(7):1102 [17]Hsia E Y, Goodson M L, Zou J X, et al. Nuclear receptor coregulators as a new paradigm for therapeutic targeting[J]. Adv Drug Deliv Rev, 2010,62(13):1227
[18]Wang Y, Lonard D M, Yu Y, et al. Small molecule inhibition of the steroid receptor coactivators, SRC-3 and SRC-1[J]. Mol Endocrinol, 2011,25(12):2041
[19]Wang Y, Lonard D M, Yu Y, et al. Bufalin is a potent Small-Molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1[J]. Cancer Res, 2014,74(5):1506
[20]Khan J A, Tikad A, Fay M, et al. A new strategy for selective targeting of progesterone receptor with passive antagonists[J]. Mol Endocrinol, 2013,27(6):909
[21]Taylor B S, Schultz N, Hieronymus H, et al. Integrative genomic profiling of human prostate Cancer[J]. Cancer Cell, 2010,18(1):11

相似文献/References:

备注/Memo

备注/Memo:
作者简介 刘雅博(1975-), 女, 主治医师,硕士,研究方向:妇产科;E-mail:yabo_l@hotmail.com。
更新日期/Last Update: 2014-07-09